Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-06

FDA Approved: LEUPROLIDE ACETATE — Original Application (Eugia US LLC)

View source ↗

Summary

The FDA approved Eugia US LLC's generic Leuprolide Acetate under an Original Application (ANDA 212963), making a generic version of this medication available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leuprolide acetate (Leuprolide acetate)

Snippet

ORIG AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)